148 related articles for article (PubMed ID: 29880736)
1.
Li G; Cheng J; Mei S; Wu T; Ye T
Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29880736
[TBL] [Abstract][Full Text] [Related]
2. Effects of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins on Hepatocellular Carcinoma Cells.
Zhou Y; Wang Q; Ying Q; Zhang X; Chen K; Ye T; Li G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835232
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic Vaccinia Virus Expressing
Wu T; Xiang Y; Liu T; Wang X; Ren X; Ye T; Li G
Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31248066
[TBL] [Abstract][Full Text] [Related]
4. A Comparative Study of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins in Breast Cancer Cells.
Zhou Y; Wang Q; Ying Q; Zhang X; Ye T; Chen K; Li G
Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827118
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo.
Wang X; Zhou N; Liu T; Jia X; Ye T; Chen K; Li G
Mar Drugs; 2021 May; 19(6):. PubMed ID: 34064193
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic Vaccinia Virus Harboring
Jiang R; Qiu Y; Zhang X; Zhou N; Jia X; Chen K; Zhou Y; Ye T; Li G
Mar Drugs; 2022 Jun; 20(6):. PubMed ID: 35736181
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic Vaccinia Virus Carrying
Zheng X; Xu W; Ying Q; Ni J; Jia X; Zhou Y; Ye T; Li G; Chen K
Mar Drugs; 2022 Oct; 20(11):. PubMed ID: 36354990
[No Abstract] [Full Text] [Related]
8.
Li G; Mei S; Cheng J; Wu T; Luo J
Mar Drugs; 2018 Apr; 16(5):. PubMed ID: 29701680
[TBL] [Abstract][Full Text] [Related]
9. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic Vaccinia Virus Harboring
Ni J; Feng H; Xu X; Liu T; Ye T; Chen K; Li G
Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677432
[No Abstract] [Full Text] [Related]
11. Targeting gene-virus-mediated manganese superoxide dismutase effectively suppresses tumor growth in hepatocellular carcinoma in vitro and in vivo.
Huang F; Ma B; Wang Y; Xiao R; Kong Y; Zhou X; Xia D
Cancer Biother Radiopharm; 2014 Dec; 29(10):403-11. PubMed ID: 25414976
[TBL] [Abstract][Full Text] [Related]
12. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans.
Breitbach CJ; Arulanandam R; De Silva N; Thorne SH; Patt R; Daneshmand M; Moon A; Ilkow C; Burke J; Hwang TH; Heo J; Cho M; Chen H; Angarita FA; Addison C; McCart JA; Bell JC; Kirn DH
Cancer Res; 2013 Feb; 73(4):1265-75. PubMed ID: 23393196
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activity.
Fu X; Rivera A; Tao L; Zhang X
Mol Ther; 2012 Oct; 20(10):1871-81. PubMed ID: 22692498
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer.
Samson A; Bentham MJ; Scott K; Nuovo G; Bloy A; Appleton E; Adair RA; Dave R; Peckham-Cooper A; Toogood G; Nagamori S; Coffey M; Vile R; Harrington K; Selby P; Errington-Mais F; Melcher A; Griffin S
Gut; 2018 Mar; 67(3):562-573. PubMed ID: 27902444
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
Deng L; Fan J; Guo M; Huang B
Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
[TBL] [Abstract][Full Text] [Related]
18. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
19. Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps.
Kober C; Rohn S; Weibel S; Geissinger U; Chen NG; Szalay AA
J Transl Med; 2015 Jul; 13():216. PubMed ID: 26149494
[TBL] [Abstract][Full Text] [Related]
20. Combinatory effects of vaccinia virus VG9 and the STAT3 inhibitor Stattic on cancer therapy.
Yang R; Wang L; Sheng J; Huang Q; Pan D; Xu Y; Yan J; Wang X; Dong Z; Yang M
Arch Virol; 2019 Jul; 164(7):1805-1814. PubMed ID: 31087190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
